BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15142421)

  • 1. Inhibition of cyclooxygenase-2 by NS-398 following hemorrhage and subsequent sepsis: no beneficial effects in either gender.
    Kahlke V; Seidel M; Stapela S; Brötzmann K; Schafmayer C; Schröder J
    Surg Infect (Larchmt); 2004; 5(1):29-37. PubMed ID: 15142421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2-mediated regulation of Kupffer cell interleukin-6 production following trauma-hemorrhage and subsequent sepsis.
    Knöferl MW; Diodato MD; Schwacha MG; Cioffi WG; Bland KI; Chaudry IH
    Shock; 2001 Dec; 16(6):479-83. PubMed ID: 11770048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early interleukin-10 treatment improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis.
    Kahlke V; Dohm C; Mees T; Brötzmann K; Schreiber S; Schröder J
    Shock; 2002 Jul; 18(1):24-8. PubMed ID: 12095129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age- and gender-related differences of the immune function in a murine model of hemorrhagic shock: IL-10 restores immunodepression in aged females without reduction of mortality.
    Mees ST; Dohm C; Broetzmann K; Schroeder J; Faendrich F; Kremer B; Kahlke V
    Langenbecks Arch Surg; 2007 Sep; 392(5):629-38. PubMed ID: 17334776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis.
    Diodato MD; Knöferl MW; Schwacha MG; Bland KI; Chaudry IH
    Cytokine; 2001 May; 14(3):162-9. PubMed ID: 11396994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
    J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
    Mack Strong VE; Mackrell PJ; Concannon EM; Mestre JR; Smyth GP; Schaefer PA; Stapleton PP; Daly JM
    J Surg Res; 2001 Jun; 98(1):40-6. PubMed ID: 11368536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival.
    Strong VE; Mackrell PJ; Concannon EM; Naama HA; Schaefer PA; Shaftan GW; Stapleton PP; Daly JM
    Shock; 2000 Sep; 14(3):374-9. PubMed ID: 11028559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis.
    Schneider CP; Nickel EA; Samy TS; Schwacha MG; Cioffi WG; Bland KI; Chaudry IH
    Shock; 2000 Sep; 14(3):347-53. PubMed ID: 11028555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats.
    Li B; Li YM; Li X; Shi B; He MY; Zhu XL; Zhou WC; Wachtel MS; Frezza E
    J Surg Res; 2009 Nov; 157(1):43-7. PubMed ID: 19765729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androstenediol ameliorates alterations in immune cells cytokine production capacity in a two-hit model of trauma-hemorrhage and sepsis.
    Suzuki T; Shimizu T; Szalay L; Choudhry MA; Rue LW; Bland KI; Chaudry IH
    Cytokine; 2006 Apr; 34(1-2):76-84. PubMed ID: 16737821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
    Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
    J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury.
    Schwacha MG; Chung CS; Ayala A; Bland KI; Chaudry IH
    Am J Physiol Cell Physiol; 2002 Feb; 282(2):C263-70. PubMed ID: 11788337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-related therapy: early IL-10 administration after hemorrhage restores immune function in males but not in females.
    Kahlke V; Dohm C; Brötzmann K; Schreiber S; Schröder J
    Shock; 2000 Sep; 14(3):354-9; discussion 359-60. PubMed ID: 11028556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis.
    Zellweger R; Zhu XH; Wichmann MW; Ayala A; DeMaso CM; Chaudry IH
    J Immunol; 1996 Dec; 157(12):5748-54. PubMed ID: 8955229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge.
    Wichmann MW; Haisken JM; Ayala A; Chaudry IH
    J Surg Res; 1996 Oct; 65(2):109-14. PubMed ID: 8903455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rats.
    Hara K; Kong DL; Sharp FR; Weinstein PR
    Neurosci Lett; 1998 Oct; 256(1):53-6. PubMed ID: 9832215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of dehydroepiandrosterone in proestrus female mice after trauma-hemorrhage.
    Knoferl MW; Angele MK; Catania RA; Diodato MD; Bland KI; Chaudry IH
    J Appl Physiol (1985); 2003 Aug; 95(2):529-35. PubMed ID: 12692147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.